OKYO Pharma Ltd ADR (OKYO) — Net Asset Quality Index
OKYO Pharma Ltd ADR (OKYO) has a Net Asset Quality Index of -73.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.64 Million minus total liabilities of $8.06 Million yields net assets of $-3.42 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can OKYO Pharma Ltd ADR fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
OKYO Pharma Ltd ADR Net Asset Quality Index Over Time (2008–2025)
This chart shows how OKYO Pharma Ltd ADR's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of September 2025, the index stands at -73.5%, representing net assets of $-3.42 Million against total assets of $4.64 Million USD. Explore OKYO Pharma Ltd ADR operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for OKYO Pharma Ltd ADR (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for OKYO Pharma Ltd ADR from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see OKYO market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -150.9% | $-5.55 Million | $3.68 Million | $9.23 Million | ▲ +230.6 pp |
| 2024 | -381.5% | $-5.88 Million | $1.54 Million | $7.42 Million | ▼ -342.0 pp |
| 2023 | -39.5% | $-2.05 Million | $5.20 Million | $7.26 Million | ▼ -108.0 pp |
| 2022 | 68.5% | $2.95 Million | $4.30 Million | $1.35 Million | ▼ -6.5 pp |
| 2021 | 75.0% | $5.32 Million | $7.09 Million | $1.77 Million | ▲ +98.4 pp |
| 2020 | -23.4% | $-139.80K | $597.40K | $737.20K | ▼ -67.2 pp |
| 2019 | 43.8% | $333.14K | $759.86K | $426.72K | ▼ -51.6 pp |
| 2018 | 95.5% | $1.92 Million | $2.01 Million | $91.06K | ▼ -3.6 pp |
| 2017 | 99.1% | $27.50 Million | $27.76 Million | $258.76K | ▼ -0.4 pp |
| 2016 | 99.4% | $32.00 Million | $32.18 Million | $181.34K | ▼ -0.1 pp |
| 2015 | 99.6% | $33.90 Million | $34.05 Million | $151.07K | ▲ +0.1 pp |
| 2014 | 99.5% | $46.96 Million | $47.21 Million | $247.95K | ▼ -0.1 pp |
| 2013 | 99.6% | $45.02 Million | $45.20 Million | $183.32K | ▲ +1.6 pp |
| 2012 | 98.0% | $41.36 Million | $42.20 Million | $832.89K | ▼ -1.5 pp |
| 2011 | 99.5% | $16.01 Million | $16.09 Million | $78.74K | ▼ -0.3 pp |
| 2010 | 99.9% | $54.05 Million | $54.13 Million | $79.87K | ▲ +0.1 pp |
| 2009 | 99.8% | $38.18 Million | $38.27 Million | $85.96K | ▲ +0.3 pp |
| 2008 | 99.5% | $27.46 Million | $27.60 Million | $144.86K | — |